Jeffrey S. Ross, MD

Articles by Jeffrey S. Ross, MD

42 Tissue and Liquid Biopsy–Based Comprehensive Genomic Profiling Reveal Mechanisms of Therapy Resistance and Rare Targetable Alterations in Breast Cancer

ByEthan Sokol,Smruthy Sivakumar,Dexter X. Jin,Hanna Tukachinsky,Karthikeyan Murugesan,Dean Pavlick,Jeffrey S. Ross, MD,Garrett M. Frampton,Geoffrey R. Oxnard, MD,Priti S. Hegde

April 18th 2022

DNA Ploidy and Cell Cycle Analysis in Cancer Diagnosis and Prognosis

ByJeffrey S. Ross, MD

June 1st 1996

This review focuses on the clinical utility and potential value of cell cycle analysis and DNA ploidy interpretation in the diagnosis of human tumors, the application of these techniques to cytologic diagnosis, and their capability

Latest Updated Articles

DNA Ploidy and Cell Cycle Analysis in Cancer Diagnosis and Prognosis
Published: June 1st 1996 | Updated:

Jeffrey S. Ross, MD

Articles by Jeffrey S. Ross, MD

42 Tissue and Liquid Biopsy–Based Comprehensive Genomic Profiling Reveal Mechanisms of Therapy Resistance and Rare Targetable Alterations in Breast Cancer

DNA Ploidy and Cell Cycle Analysis in Cancer Diagnosis and Prognosis

Latest Updated Articles

Trending on CancerNetwork

MCS-8, a Plant-Derived Drug, Reduces Prostate Cancer Incidence vs Placebo

Promises and Problems in Brain Cancer Therapy: What’s Hot Right Now?

Darolutamide/ADT Improves Efficacy in Older Metastatic HSPC Population

Decision-Making Capacity: The Ethical Core of Patient-Centered Oncology

Personalized Medicine and Targeted Therapy May Hold Promise in Lung Cancer